Your enquiry has been submitted
Fluid Thioglycollate Medium (Thioglycollate Medium, Fluid)
Intended Use
Recommended for sterility testing of biologicals and for cultivation of anaerobes, aerobes and microaerophiles from pharmaceutical and clinical samples.
Composition
| Ingredients | g/L |
|---|---|
| Tryptone | 15.000 |
| Yeast extract | 5.000 |
| Dextrose (Glucose) | 5.500 |
| Sodium chloride | 2.500 |
| L-Cystine | 0.500 |
| Sodium thioglycollate | 0.500 |
| Resazurin sodium | 0.001 |
| Agar | 0.750 |
Final pH (at 25°C): 7.1±0.2
**Formula adjusted, standardized to suit performance parameters
Directions
Suspend 29.75 grams in 1000 ml purified/distilled water. Heat to boiling to dissolve the medium completely. Sterilize by autoclaving at 15 lbs pressure (121°C) for 15 minutes. Cool to 25°C and store in a cool dark place preferably below 25°C.
Note: If more than the upper one-third of the medium has acquired a pink-purple colour, the medium may be restored once by heating in a water bath or in free flowing steam until the pink-purple colour disappears.
Principle And Interpretation
Brewer (1) formulated Fluid Thioglycollate Medium for rapid cultivation of aerobes as well as anaerobes including microaerophiles by adding a reducing agent and small amount of agar. The BP (2), EP (3), USP (4), and AOAC (5) have recommended the media for sterility testing of antibiotics, biologicals and foods and for determining the phenol coefficient and sporicidal effect of disinfectants. However, it is intended for the examination of clear liquid or water-soluble materials. Fluid Thioglycollate Medium is also routinely used to check the sterility of stored blood in blood banks (6).
Dextrose, tryptone, yeast extract, L-cystine provide the growth factors necessary for bacterial multiplication. L-cystine and sodium thioglycollate allows Clostridium to grow in this medium even under aerobic conditions (7). Also the small amount of agar used in the medium favors the growth of aerobes as well as anaerobes in the medium, even if sodium thioglycollate is deleted from the medium(1). Sodium thioglycollate act as a reducing agent and neutralizes the toxic effects of mercurial preservatives and peroxides formed in the medium, thereby promoting anaerobiosis, and making the medium suitable to test materials containing heavy metals. (8,9). Any increase in the oxygen content is indicated by a colour change of redox indicator, resazurin to red (6,10,11). The small amount of agar helps in maintaining low redox potential for stabilizing the medium (9).
Type of specimen
Pharmaceutical samples for sterility testing, clinical samples- pus, wounds
Specimen Collection and Handling:
For clinical samples follow appropriate techniques for handling specimens as per established guidelines (12,13).
For pharmaceutical samples, follow appropriate techniques for sample collection, processing as per guidelines (2,3,4) After use, contaminated materials must be sterilized by autoclaving before discarding.
Warning and Precautions
In Vitro diagnostic Use. For professional use only. Read the label before opening the container. Wear protective gloves/protective clothing/eye protection/ face protection. Follow good microbiological lab practices while handling specimens and culture. Standard precautions as per established guidelines should be followed while handling clinical specimens. Safety guidelines may be referred in individual safety data sheets.
Limitations
- 1. It is intended for the examination of clear liquid or water-soluble materials.
Performance and Evaluation
Performance of the medium is expected when used as per the direction on the label within the expiry period when stored at recommended temperature.
Quality Control
Appearance: Cream to yellow homogeneous free flowing powder
Colour and Clarity of prepared medium: Light straw coloured, clear to slightly opalescent solution with upper 10% or less medium pink-purple on standing.
Reaction: Reaction of 2.97% w/v aqueous solution at 25°C. pH: 7.1±0.2
pH: 6.90-7.30
Growth Promotion Test: As per USP/EP/BP/IP
Growth promoting properties: Clearly visible growth of microorganism comparable to that previously obtained with previously tested and approved lot of medium occurs at the specified temperature for not more than the shortest period of time specified inoculating <=100 cfu at 30-35°C for or not more than 3 days for aerobes and anaerobes.
Sterility Testing + Validation: The medium is tested with suitable strains of microrganisms inoculating <=100cfu and incubating at 20-25°C for not more than 3 days in case of bacteria and not more than 5 days in case of fungi.
Testing in accordance with EN ISO 11133:2014/Amd.1:2018(E) (10): Cultural characteristics observed after an incubation at 36-38°C for 18-24 hours
Growth promoting (30-35°C)
| Organism | Inoculum (CFU) | Growth | Incubation at |
|---|---|---|---|
| Staphylococcus aureus subsp. aureus ATCC 6538 (00032*) | 50-100 | luxuriant | 30-35°C |
| Staphylococcus aureus subsp. aureus ATCC 25923 (00034*) ^ | 50-100 | luxuriant | 30-35°C |
| $ Bacillus spizizenii ATCC 6633 (00003*) | 50-100 | luxuriant | 30-35°C |
| ^Pseudomonas paraeruginosa ATCC 9027 (00026*) | 50-100 | luxuriant | 30-35°C |
| ##Kocuria rhizophila ATCC 9341 | 50-100 | luxuriant | 30-35°C |
| Clostridium sporogenes ATCC 19404 (00008*) | 50-100 | luxuriant | 30-35°C |
| Clostridium sporogenes ATCC 11437 | 50-100 | luxuriant | 30-35°C |
| $Phocaeicola vulgatus ATCC 8482 | 50-100 | luxuriant | 30-35°C |
| Escherichia coli ATCC 8739 (00012*) | 50-100 | luxuriant | 30-35°C |
| Salmonella Typhimurium ATCC 14028 (00031*) | 50-100 | luxuriant | 30-35°C |
| Salmonella Abony NCTC 6017 | 50-100 | luxuriant | 30-35°C |
Sterility Testing- Growth promotion + Validation (20-25°C)
| Organism | Inoculum (CFU) | Growth | Incubation at |
|---|---|---|---|
| Staphylococcus aureus subsp. aureus ATCC 6538 (00032*) | 50-100 | luxuriant | 20-25°C |
| $ Bacillus spizizenii ATCC 6633 (00003*) | 50-100 | luxuriant | 20-25°C |
| ^Pseudomonas paraeruginosa ATCC 9027 (00026*) | 50-100 | luxuriant | 20-25°C |
| ##Kocuria rhizophila ATCC 9341 | 50-100 | luxuriant | 20-25°C |
| Candida albicans ATCC 10231 (00054*) | 50-100 | luxuriant | 20-25°C |
| #Aspergillus brasiliensis ATCC 16404 (00053*) | 50-100 | luxuriant | 20-25°C |
Cultural characteristics observed (36-38°C)
Cultural characteristics observed after an incubation at 36-38°C for 18-24 hours
| Organism | Inoculum (CFU) | Growth | Incubation at |
|---|---|---|---|
| Clostridium perfringens ATCC 13124 (00007*) | 50-100 | luxuriant | 36-38°C |
Key:
- * Corresponding WDCM numbers,
- ## Formerly known as Micrococcus luteus
- $ Formerly known as Bacteroides vulgatus
- # Formerly known as Aspergillus niger,
- $ Formerly known as Bacillus subtilis subsp. spizizenii
- ^ Formerly known as Pseudomonas aeruginosa
Disposal
User must ensure safe disposal by autoclaving and/or incineration of used or unusable preparations of this product. Follow established laboratory procedures in disposing of infectious materials and material that comes into contact with clinical sample must be decontaminated and disposed of in accordance with current laboratory techniques (12,13).
Reference
- Brewer, 1940, J. Am. Med. Assoc., 115:598.
- The British Pharmacopoeia, 2022, Medicines and Healthcare products Regulatory Agency.
- European Pharmacopoeia, 2022, 10 th volume, European Directorate for the quality of medicines & Healthcare.
- The United States Pharmacopoeia-National Formulatory (USP-NF), 2022
- Williams H., (Ed.), 2005, Official Methods of Analysis of the Association of Official Analytical Chemists, 19th Ed., AOAC,Washington, D.C
- Nungester, Hood and Warren, 1943, Proc. Soc. Exp. Biol. Med., 52:287.
- Portwood, 1944, J. Bact., 48:255.
- Federal Register, 1992, Fed. Regist., 21:640.
- Quastel and Stephenson, 1926, J.Biochem., 20
- Marshall, Gunnison and Luxen, 1940, Proc. Soc. Exp. Biol. Med., 43:672.
- MacFaddin J.F., 1985, Media for Isolation-Cultivation-Identification-Maintenance of Medical Bacteria, Vol. 1, Williams and Wilkins, Baltimore.
- Isenberg, H.D. Clinical Microbiology Procedures Handbook 2nd Edition.
- Jorgensen, J.H., Pfaller, M.A., Carroll, K.C., Funke, G., Landry, M.L., Richter, S.S and Warnock., D.W. (2015) Manual of Clinical Microbiology, 11th Edition. Vol. 1.
| Product Name | Fluid Thioglycollate Medium (Thioglycollate Medium, Fluid) |
|---|---|
| SKU | M009 |
| Product Type | Regular |
| Physical Form | Powder |
| Origin | Animal |
| Packaging type | HDPE |
| References | 1.Brewer, 1940, J. Am. Med. Assoc., 115:598. 2.The United States Pharmacopoeia, 2018, The United States Pharmacopoeial Convention, Rockville, MD. 3.British Pharmacopoeia, 2016, The Stationery office British Pharmacopoeia4.European Pharmacopoeia, 2017, European Dept. for the quality of Medicines. 5.Williams H., (Ed.), 2005, Official Methods of Analysis of the Association of Official Analytical Chemists, 19th Ed., AOAC,Washington, D.C 6.Marshall, Gunnison and Luxen, 1940, Proc. Soc. Exp. Biol. Med., 43:672. 7.Nungester, Hood and Warren, 1943, Proc. Soc. Exp. Biol. Med., 52:287. 8.Portwood, 1944, J. Bact., 48:255. 9.MacFaddin J.F., 1985, Media for Isolation-Cultivation-Identification-Maintenance of Medical Bacteria, Vol. 1, Williamsand Wilkins, Baltimore. 10.Federal Register, 1992, Fed. Regist., 21:640.0.. 11. Quastel and Stephenson, 1926, J.Biochem., 20:1.. 12.Isenberg, H.D. Clinical Microbiology Procedures Handb0ook. 2nd Edition.13Jorgensen,J.H., Pfaller , M.A., Carroll, K.C., Funke, G., Landry, M.L., Richter, S.S and Warnock., D.W. (2015)Manual of Clinical Microbiology, 11th Edition. Vol. 1. |
Case studies of Fluid Thioglycollate Medium
Case 1:
- Problem: In pharmaceutical and biologics quality control, sterility testing is essential. However, laboratories often struggle to detect low-level contamination when culture media fails to adequately support both aerobic and anaerobic microorganisms. This can result in false negatives, delayed batch release, and increased operational costs.
- Solution: HiMedia’s Fluid Thioglycollate Medium is carefully formulated and standardized to comply with pharmacopoeial performance requirements (USP, EP, BP, and IP) for sterility testing of liquid and clear biological products. By maintaining a low redox potential through the use of reducing agents, it supports the growth of a wide range of aerobic and anaerobic microorganisms, thereby enhancing the detection of contaminants that may go undetected with less optimized media.
- Result: Independent pharmacopoeial evaluations have demonstrated that Fluid Thioglycollate Medium is among the most effective media for sterility testing within compendial methods. Comparative studies indicate that thioglycollate-based media consistently achieve high recovery rates of pharmacopoeial test organisms, highlighting their robust support for both aerobic and anaerobic microorganisms.
Case 2:
- Problem: Pharmaceutical QC laboratories frequently experience ambiguous sterility test results, especially with slow-growing or stressed microorganisms. This often leads to repeat testing, delayed batch release, and increased workload for analysts.
- Solution: HiMedia’s Fluid Thioglycollate Medium provides a stable, low-oxygen environment that supports the recovery of stressed and slow-growing microorganisms. Its optimized nutrient composition enables clearer and more reliable microbial growth during the incubation period.
- Result:
- Retesting reduced by approximately 20–25% due to clearer growth outcomes.
- Faster decision-making for batch release.
Case 3:
- Problem: During FDA and regulatory inspections, laboratories are often questioned regarding the performance and suitability of sterility testing media, particularly growth promotion capability and lot-to-lot consistency.
- Solution: HiMedia’s Fluid Thioglycollate Medium is manufactured and quality-tested in accordance with USP, EP, BP, and IP requirements, with documented growth promotion testing for compendial organisms.
- Result:
- Improved confidence during regulatory audits.
- Fewer audit observations related to sterility testing media.
- Clear documentation supporting media performance and compliance.
Case 4:
- Problem: Biologics and complex formulations can stress microorganisms, making contamination harder to detect during sterility testing.
- Solution: HiMedia Fluid Thioglycollate Medium is designed to support the recovery of stressed microorganisms by providing essential nutrients while maintaining suitable redox conditions.
- Result:
- Improved recovery of stressed microorganisms.
- More reliable sterility test outcomes for biologics.
- Reduced risk of false-negative results.
What is the difference between standard FTM and HiVeg™ Fluid Thioglycollate Medium?
What are the safety precautions for using Fluid Thioglycollate Medium?
Fluid Thioglycollate Medium (FTM) is widely used for sterility testing and the cultivation of aerobic and anaerobic microorganisms. To ensure reliable results and safe laboratory practice, the following safety precautions should be observed:
- Proper Preparation and Handling: Prepare the medium strictly according to pharmacopeial instructions. Avoid excessive heating or repeated reheating, as this can generate toxic oxidative by-products and compromise the reducing capacity of the medium.
- Monitoring of Redox Indicator: Inspect the resazurin indicator before use. If pink coloration extends beyond one-third of the medium column, the medium should be discarded, as this indicates excessive oxygen exposure and loss of anaerobic conditions.
- Aseptic Technique: Handle FTM under strict aseptic conditions to prevent accidental contamination, which may lead to false-positive sterility results and unnecessary investigations.
- Temperature and Storage Control: Store prepared media at recommended temperatures and protect from light to maintain chemical stability and redox balance. Do not use media beyond the validated shelf life.
- Personal Protective Equipment (PPE): Use appropriate PPE, including laboratory coats, gloves, and eye protection, when handling media and test samples to minimize exposure to potentially hazardous microorganisms.
- Waste Disposal: Once testing is complete, treat all used media as biohazardous waste and dispose of it safely in accordance with laboratory biosafety protocols and applicable local regulations.
Adhering to these precautions ensures operator safety, preserves the functional integrity of Fluid Thioglycollate Medium, and supports accurate and compliant sterility testing outcomes.
Where can I find the Technical Data Sheet for this product?
All technical documentation, including TDS, SDS, and COA, is available on our localized US portal.
- Visit www.himedialabs.com/us.
- Search for your specific product code (e.g., M009 for the standard USP formulation).
- High-volume users can also request bulk-batch COAs directly from our Pennsylvania-based support team.
- For Technical & Product Support:
Email: infous@himedialabs.com
Why is sterility testing important in pharmaceuticals?
Sterility testing is a critical component of quality assurance in pharmaceutical manufacturing. For products intended to be sterile, such as parenteral formulations, ophthalmic preparations, and surgical implants, it serves as the final microbiological confirmation that the manufacturing and sterilization processes have successfully eliminated all viable contaminating microorganisms.
- Patient Safety & Clinical Outcomes: Beyond preventing sepsis, sterility testing plays a vital role in protecting immunocompromised patients from opportunistic pathogens. Even low-level microbial contamination in large volume parenteral can induce pyrogenic reactions or progress to systemic organ failure, highlighting the serious clinical consequences of compromised sterility.
- Regulatory Compliance & Legal Protection: Compliance with USP <71> is not optional; it is a mandatory requirement for pharmaceutical products to enter and remain in the US market. Failure to meet these requirements can result in FDA Form 483 observations, Warning Letters, or Consent Decrees. Implementing rigorous sterility testing protocols provides clear evidence that the manufacturer has exercised due diligence and is complied with recognized pharmacopeial standards.
- Process Validation & Aseptic Control: Sterility testing serves as a definitive validation of a facility’s 'State of Control.' It provides the empirical data required to confirm that all aseptic variables—ranging from HVAC filtration efficiency and sterilization cycles (Autoclave/EtO) to cleanroom behavior and human intervention—are functioning within validated parameters to ensure a sterile output.
- Economic Risk Mitigation: The cost of a product recall often runs into millions of dollars, far exceeding the cost of robust microbiological media. By using high-performance media like HiMedia FTM, labs reduce the risk of False Negatives (undetected contamination) and False Positives (media-related contamination), both of which cause massive operational delays.
- Supply Chain Integrity: In a globalized market, sterility testing ensures that products manufactured at a site maintain their biological purity throughout the supply chain until they reach the healthcare provider.
How is Fluid Thioglycollate Medium prepared?
- Reconstitution: Suspend 29.75g (or the precise amount indicated on your specific HiMedia lot label) of dehydrated powder in 1000 ml of high-purity distilled or deionized water. Consistent water quality is essential to prevent mineral interference with the medium’s redox potential.
- Dissolution: Gradually heat the suspension to a boiling point while stirring continuously. This ensures that the agar, which provides the required viscosity to prevent oxygen convection, and the other nutrients are completely and uniformly dissolved. Such uniformity is critical for maintaining a stable oxygen gradient later.
- Sterilization: Autoclave at 121°C (15 lbs pressure) for 15 minutes. It is critical not to exceed this time; over-autoclaving can lead to the "browning" of the medium (Maillard reaction), which caramelizes the dextrose and can inhibit the growth of fastidious organisms.
- Cooling & Storage: Cool the sterilized medium immediately to 25°C and store it in a cool, dark place (ideally 15–25°C). Prompt cooling helps set the agar properly, creating the physical barrier needed to limit oxygen diffusion.
What is Fluid Thioglycollate Medium used for?
• Aerobe/Anaerobe Cultivation: It is unique because it supports the growth of obligate anaerobes (like Clostridium sporogenes), obligate aerobes (like Pseudomonas aeruginosa), and facultative anaerobes within a single tube.
• Preservative Neutralization: It is the medium of choice for testing products containing mercurial preservatives, as the sulfhydryl (-SH) groups in the medium neutralize their antimicrobial effects.





















